A5058198948- Multiple Sclerosis Research Studies
- Acute Ischemic Stroke Management
- Long-Term Effects of COVID-19
- Retinal and Optic Conditions
- Cerebrovascular and Carotid Artery Diseases
- Polyomavirus and related diseases
- COVID-19 and healthcare impacts
- Research on Leishmaniasis Studies
- SARS-CoV-2 and COVID-19 Research
- Ocular Diseases and Behçet’s Syndrome
- Systemic Sclerosis and Related Diseases
- Neurological Complications and Syndromes
- Pregnancy and preeclampsia studies
- Systemic Lupus Erythematosus Research
- Cerebral Venous Sinus Thrombosis
- Vestibular and auditory disorders
- Cardiac Imaging and Diagnostics
- Vasculitis and related conditions
- Autoimmune and Inflammatory Disorders Research
- Blood groups and transfusion
- Spinal Fractures and Fixation Techniques
- COVID-19 Pandemic Impacts
- Multiple Myeloma Research and Treatments
- Toxin Mechanisms and Immunotoxins
- Sphingolipid Metabolism and Signaling
Cleveland Clinic
2020-2023
Helsinki University Hospital
2021
Radboud University Medical Center
2021
Radboud University Nijmegen
2021
University of Helsinki
2021
Instituto Nacional de Neurología y Neurocirugía
2021
Abu Dhabi Health Services
2019-2020
The Neurological Institute
2020
King's College Hospital NHS Foundation Trust
2013
King's College Hospital
2004
<h3>SUMMARY:</h3> The mechanisms and phenotype of ischemic stroke associated with coronavirus disease 2019 (COVID-19) remain uncertain. A retrospective study was conducted in patients COVID-19 presenting from March 1 to May 25, 2020, cases large-vessel occlusion were identified. To provide baseline institutional data within outside the pandemic, all consecutive TIA admissions (COVID non-COVID) hospital during a 10-week period 10, collected compared same time 2019. Among 20 acute stroke, 15...
Worldwide, 2 million patients aged 18-50 years suffer a stroke each year, and this number is increasing. Knowledge about global distribution of risk factors aetiologies, information prognosis optimal secondary prevention in young are limited. This limits evidence-based treatment hampers the provision appropriate regarding causes stroke, patients.
Inconvenient administration and side effects of some disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) can deter adherence. We evaluated treatment satisfaction with cladribine tablets (CladT) RMS in the Arabian Gulf. This was a non-interventional, multicentre, prospective observational study non-pregnant/lactating adults (aged ≥ 18 years) eligible 1st CladT (EU labelling). The primary outcome overall at 6 months (Treatment Satisfaction Questionnaire Medication...
A man aged 23 years, with a previous clinical diagnosis of Behcet disease (recurrent genital and oral ulceration papulopustular rash), sought treatment for 3-week history headache, fever, progressive right-sided weakness. Clinical examination revealed right homonymous hemianopia …
The pathophysiology of focal spinal cord MRI T2 hyperintensity (SCHI) in patients with cervical spondylosis is uncertain. This study was undertaken to determine the frequency and cause SCHI. authors reviewed serial spine magnetic resonance imaging (MRI) reports scans compression or noted location, shape, extent SCHI, severity (expressed as a score [SS]). recorded age vascular risk factors for each patient. Nineteen 273 (7%) 19 36 (53%) had SCHI extended one vertebral level from 12 three...
The coexistence of multiple autoimmune diseases in the same individual is unusual and has received little attention literature. We present a young female patient with sclerosis, systemic lupus erythematosus, biopsy-proven renal proteinase 3 antineutrophil cytoplasmic antibodyassociated vasculitis who responded well to intravenous rituximab clinically serologically.